Michael A. Caligiuri

机构：City of Hope · ORCID：0000-0002-4095-3020

发表论文 873 篇 · 总被引 71005 次 · h-index 135

代表论文

YTHDF2: a key RNA reader and antitumor target (2025 · Trends in Immunology · 被引 30)
Natural killer cell–based immunotherapy for cancer (2025 · The Journal of Immunology · 被引 30)
Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy (2025 · Nature Immunology · 被引 13)
Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice (2025 · Journal of Clinical Investigation · 被引 12)
Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 10)
Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors (2025 · JCI Insight · 被引 10)